Ignite Creation Date:
2024-05-06 @ 7:18 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05961592
Status:
RECRUITING
Last Update Posted:
2024-01-19
First Post:
2023-07-18
Brief Title:
R-2487 in Patients With Rheumatoid Arthritis
Sponsor:
Rise Therapeutics LLC
Organization:
Rise Therapeutics LLC
Study Overview
Official Title:
A Single and Repeat Dosing Study of the Safety Drug Exposure and Clinical Activity of R-2487 in Patients With Rheumatoid Arthritis
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
R-2487-RA01
Brief Summary:
The goal of this study is to determine the safety and tolerability of orally taken probiotic R-2487 in patients with Rheumatoid Arthritis
Patients will take an oral dosage of probiotic R-2487 and physicians will assess and measure their Rheumatoid Arthritis Blood and fecal evaluations of inflammation and assessment of probiotic R-2487 on fecal level will also be measured
Patients will take an oral dosage of probiotic R-2487 and physicians will assess and measure their Rheumatoid Arthritis Blood and fecal evaluations of inflammation and assessment of probiotic R-2487 on fecal level will also be measured
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None